These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8249053)

  • 21. Highly sensitive determination of imidapril, a new angiotensin I-converting enzyme inhibitor, and its active metabolite in human plasma and urine using high-performance liquid chromatography with fluorescent labelling reagent.
    Tagawa K; Hayashi K; Mizobe M; Noda K
    J Chromatogr; 1993 Jul; 617(1):95-103. PubMed ID: 8376543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of quinapril on angiotensin converting enzyme and plasma renin activity as well as pharmacokinetic parameters of quinapril and its active metabolite, quinaprilat, after intravenous and oral administration to mature horses.
    Davis JL; Kruger K; LaFevers DH; Barlow BM; Schirmer JM; Breuhaus BA
    Equine Vet J; 2014 Nov; 46(6):729-33. PubMed ID: 24175935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous quantification of enalapril and enalaprilat in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study.
    Lu S; Jiang K; Qin F; Lu X; Li F
    J Pharm Biomed Anal; 2009 Jan; 49(1):163-7. PubMed ID: 19046843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of bisaramil and its metabolite in plasma using high-performance liquid chromatography with electrochemical detection.
    Matsushima E; Sato T
    J Chromatogr; 1992 Jan; 573(2):339-44. PubMed ID: 1601972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid conversion of the new angiotensin converting enzyme inhibitor ramipril to its active metabolite in rats.
    Tabata S; Yamazaki H; Ohtake Y; Hayashi S
    Arzneimittelforschung; 1990 Aug; 40(8):865-7. PubMed ID: 2173610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of captopril in human plasma, using solid phase extraction and high-performance liquid chromatography, coupled to mass spectrometry: application to bioequivalence study.
    Rezende KR; Mundim IM; Teixeira LS; Souza WC; Ramos DR; Cardoso CR; Souza IC; Gratão MZ; Bellório KB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):59-67. PubMed ID: 17145205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radioimmunoassays for spirapril and its active metabolite spiraprilate: performance and application.
    Hossein-Nia M; Surve AH; Weglein R; Gerbeau C; Holt DW
    Ther Drug Monit; 1992 Jun; 14(3):234-42. PubMed ID: 1384174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and pharmacodynamics of a novel orally active angiotensin converting enzyme inhibitor (HOE 498) in healthy subjects.
    Witte PU; Irmisch R; Hajdú P; Metzger H
    Eur J Clin Pharmacol; 1984; 27(5):577-81. PubMed ID: 6097458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical analysis of sampatrilat, a combined renal endopeptidase and angiotensin-converting enzyme inhibitor II: assay in the plasma and urine of human volunteers by dissociation enhanced lanthanide fluorescence immunoassay (DELFIA).
    Venn RF; Barnard G; Kaye B; Macrae PV; Saunders KC
    J Pharm Biomed Anal; 1998 Jan; 16(5):883-92. PubMed ID: 9535200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzyme immunoassay of the active metabolite (RS-5139) of angiotensin converting enzyme inhibitor (CS-622).
    Shioya H; Shimojo M; Kawahara Y
    J Immunoassay; 1991; 12(1):15-28. PubMed ID: 2040710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid quantification of lisinopril in human plasma by liquid chromatography/tandem mass spectrometry.
    Qin W; Zhang Z; Tian Y; Xu F; Wang N; Chen Y
    Biomed Chromatogr; 2007 Apr; 21(4):415-21. PubMed ID: 17221934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of food on the pharmacokinetics of perindopril and the time course of angiotensin-converting enzyme inhibition in serum.
    Lecocq B; Funck-Brentano C; Lecocq V; Ferry A; Gardin ME; Devissaguet M; Jaillon P
    Clin Pharmacol Ther; 1990 Mar; 47(3):397-402. PubMed ID: 2311339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of captopril in plasma by high-performance liquid chromatography for pharmacokinetic studies.
    Arroyo C; López-Calull C; García-Capdevila L; Gich I; Barbanoj M; Bonal J
    J Chromatogr B Biomed Sci Appl; 1997 Jan; 688(2):339-44. PubMed ID: 9061473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin-converting enzyme in macro- and microvessels of the rat.
    Jandeleit K; Jackson B; Perich R; Paxton D; Johnston C
    Clin Exp Pharmacol Physiol; 1991 May; 18(5):353-6. PubMed ID: 1648462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular remodeling in systemic hypertension.
    Gohlke P; Lamberty V; Kuwer I; Bartenbach S; Schnell A; Unger T
    Am J Cardiol; 1993 Jun; 71(17):2E-7E. PubMed ID: 8392281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of the converting enzyme inhibitor HOE 498 on the renin angiotensin system of normal volunteers.
    Bussien JP; Nussberger J; Porchet M; Waeber B; Brunner HR; Perisic M; Tansey MJ; Bomm M; Hajdu P
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Mar; 329(1):63-9. PubMed ID: 2987705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bimane fluorogenic substrates for microdetermination of angiotensin converting enzyme level in serum.
    Sato E; Hattori H; Nishikawa S; Kanaoka Y
    Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):2146-8. PubMed ID: 1665758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of enzyme-linked immunoassays for human angiotensin I converting enzyme suitable for large-scale studies.
    Danilov S; Savoie F; Lenoir B; Jeunemaitre X; Azizi M; Tarnow L; Alhenc-Gelas F
    J Hypertens; 1996 Jun; 14(6):719-27. PubMed ID: 8793694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of a single dose of ramipril in patients with renal dysfunction: comparison with essential hypertension.
    Shionoiri H; Miyakawa T; Yasuda G; Ishikawa Y; Umemura S; Miyajima E; Kaneko Y
    J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S145-7. PubMed ID: 2485051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioimmunoassay of a new angiotensin-converting enzyme inhibitor (perindopril) in human plasma and urine: advantages of coupling anion-exchange column chromatography with radioimmunoassay.
    Doucet L; De Veyrac B; Delaage M; Cailla H; Bernheim C; Devissaguet M
    J Pharm Sci; 1990 Aug; 79(8):741-5. PubMed ID: 2231339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.